The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation
Abstract
PML is a nuclear phosphoprotein that was first identified as part of a translocated chromosomal fusion product associated with acute promyelocytic leukaemia (APL). PML localises to distinct nuclear multi-protein complexes termed ND10, Kr bodies, PML nuclear bodies and PML oncogenic domains (PODs), which are disrupted in APL and are the targets for immediate early viral proteins, although little is known about their function. In a yeast two-hybrid screen, we first identified a ubiquitin-like protein named PIC1 (now known as SUMO-1), which interacts and co-localises with PML in vivo. More recent studies have now shown that SUMO-1 covalently modifies a number of target proteins including PML, RanGAP1 and IκBα and is proposed to play a role in either targeting modified proteins and/or inhibiting their degradation. The precise molecular role for the SUMO-1 modification of PML is unclear, and the specific lysine residues within PML that are targeted for modification and the PML sub-domains necessary for mediating the modification in vivo are unknown. Here we show that SUMO-1 covalently modifies PML both in vivo and in vitro and that the modification is mediated either directly or indirectly by the interaction of UBC9 with PML through the RING finger domain. Using site-specific mutagenesis, we have identified the primary PML-SUMO-1 modification site as being part of the nuclear localisation signal (Lys487 or Lys490). However SUMO-1 modification is not essential for PML nuclear localisation as only nuclear PML is modified. The sequence of the modification site fits into a consensus sequence for SUMO-1 modification and we have identified several other nuclear proteins which could also be targets for SUMO-1. We show that SUMO-1 modification appears to be dependant on the correct subcellular compartmentalisation of target proteins. We also find that the APL-associated fusion protein PML-RARA is efficiently modified in vitro, resulting in a specific and SUMO-1-dependent degradation of PML-RARA. Our results provide significant insights into the role of SUMO-1 modification of PML in both normal cells and the APL disease state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Enzymatic Amplification of DNA In Vitro: The Polymerase Chain Reaction
Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., & Erlich, H. (1986) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1986.051.01.032 · Cited by 3,558
Mahajan, R., Delphin, C., Guan, T., Gerace, L., & Melchior, F. (1997) · Cell · doi:10.1016/s0092-8674(00)81862-0 · Cited by 1,256
Matunis, M. J., Coutavas, E., & Blobel, G. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1457 · Cited by 1,197
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Self-citationA novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Conti, E., Uy, M., Leighton, L., Blobel, G., & Kuriyan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81419-1 · Cited by 783
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
Dalton, S., & Treisman, R. (1992) · Cell · doi:10.1016/0092-8674(92)90194-h · Cited by 672
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
Does this have a familiar RING?
Saurin, A. J., Borden, K. L. B., Boddy, M. N., & Freemont, P. S. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)80017-x · Cited by 635
Self-citation
Cited by
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,675
Hay, R. T. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.012 · Cited by 1,622
Self-citationMdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Bernardi, R., & Pandolfi, P. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2277 · Cited by 879
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M.-C., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E. G., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 847
Self-citationStructure of a c-Cbl–UbcH7 Complex
Zheng, N., Wang, P., Jeffrey, P. D., & Pavletich, N. P. (2000) · Cell · doi:10.1016/s0092-8674(00)00057-x · Cited by 839
Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T. H., Strauss, J. F., & Maul, G. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.221 · Cited by 832
Polymeric Chains of SUMO-2 and SUMO-3 Are Conjugated to Protein Substrates by SAE1/SAE2 and Ubc9
Tatham, M. H., Jaffray, E., Vaughan, O. A., Desterro, J. M. P., Botting, C. H., Naismith, J. H., & Hay, R. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104214200 · Cited by 821
Self-citationHatakeyama, S. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3139 · Cited by 802
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Zhang, X.-W., Yan, X.-J., Zhou, Z.-R., Yang, F.-F., Wu, Z.-Y., Sun, H.-B., Liang, W.-X., Song, A.-X., Lallemand-Breitenbach, V., Jeanne, M., et al. (2010) · Science · doi:10.1126/science.1183424 · Cited by 785
Self-citationMelchior, F. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.591 · Cited by 774
Sumo, ubiquitin's mysterious cousin
Müller, S., Hoege, C., Pyrowolakis, G., & Jentsch, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056591 · Cited by 764
SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting
Rodriguez, M. S., Dargemont, C., & Hay, R. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009476200 · Cited by 744
Self-citationArsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B., & de Thé, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1717 · Cited by 734
Self-citationTRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases
Meroni, G., & Diez‐Roux, G. (2005) · BioEssays · doi:10.1002/bies.20304 · Cited by 730
SUMO-1 modification activates the transcriptional response of p53
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639
Self-citationLallemand-Breitenbach, V., & de The, H. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000661 · Cited by 563
Self-citationUbiquitination: RING for destruction?
Freemont, P. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00287-6 · Cited by 522
Self-citationSampson, D. A., Wang, M., & Matunis, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100006200 · Cited by 519
Something about SUMO inhibits transcription
Gill, G. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.07.004 · Cited by 496
Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honoré, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1361 · Cited by 488
Self-citationUbiquitin-like proteins: new wines in new bottles
Yeh, E. T. H., Gong, L., & Kamitani, T. (2000) · Gene · doi:10.1016/s0378-1119(00)00139-6 · Cited by 469
PML protein isoforms and the RBCC/TRIM motif
Jensen, K., Shiels, C., & Freemont, P. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204765 · Cited by 467
Self-citationCovalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
Poukka, H., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14145 · Cited by 457
Involvement of PIAS1 in the Sumoylation of Tumor Suppressor p53
Kahyo, T., Nishida, T., & Yasuda, H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00349-5 · Cited by 452
The ubiquitin‐proteasome pathway and proteasome inhibitors
Myung, J., Kim, K. B., & Crews, C. M. (2001) · Medicinal Research Reviews · doi:10.1002/med.1009 · Cited by 446
PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases
Kotaja, N., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5222-5234.2002 · Cited by 425
RING domains: master builders of molecular scaffolds?
Borden, K. L. B. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3429 · Cited by 410
c-Jun and p53 Activity Is Modulated by SUMO-1 Modification
Müller, S., Berger, M., Lehembre, F., Seeler, J.-S., Haupt, Y., & Dejean, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13321 · Cited by 400
Cell Cycle–Regulated Attachment of the Ubiquitin-Related Protein Sumo to the Yeast Septins
Johnson, E. S., & Blobel, G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.5.981 · Cited by 381
Nuclear bodies: multifaceted subdomains of the interchromatin space
Matera, A. G. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01606-2 · Cited by 332
The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase
Kirsh, O. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2682 · Cited by 328
Vertegaal, A. C. O., Andersen, J. S., Ogg, S. C., Hay, R. T., Mann, M., & Lamond, A. I. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600212-mcp200 · Cited by 314
Self-citationPondering the Promyelocytic Leukemia Protein (PML) Puzzle: Possible Functions for PML Nuclear Bodies
Borden, K. L. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5259-5269.2002 · Cited by 313
Hietakangas, V., Ahlskog, J. K., Jakobsson, A. M., Hellesuo, M., Sahlberg, N. M., Holmberg, C. I., Mikhailov, A., Palvimo, J. J., Pirkkala, L., & Sistonen, L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2953-2968.2003 · Cited by 309
ICP0, a regulator of herpes simplex virus during lytic and latent infection
Everett, R. D. (2000) · BioEssays · doi:10.1002/1521-1878(200008)22:8<761::aid-bies10>3.0.co;2-a · Cited by 299
Review: Properties and Assembly Mechanisms of ND10, PML Bodies, or PODs
Maul, G. G., Negorev, D., Bell, P., & Ishov, A. M. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4239 · Cited by 287
Promyelocytic Leukemia (Pml) Nuclear Bodies Are Protein Structures That Do Not Accumulate RNA
Boisvert, F.-M., Hendzel, M. J., & Bazett-Jones, D. P. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.2.283 · Cited by 276
Jürgen Dohmen, R. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.021 · Cited by 270
Apg10p, a novel protein‐conjugating enzyme essential for autophagy in yeast
Shintani, T., Mizushima, N., Ogawa, Y., Matsuura, A., Noda, T., & Ohsumi, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5234 · Cited by 269
Buschmann, T., Fuchs, S. Y., Lee, C.-G., Pan, Z.-Q., & Ronai, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)80887-9 · Cited by 269
RetractedRegulation of Heat Shock Transcription Factor 1 by Stress-induced SUMO-1 Modification
Hong, Y., Rogers, R., Matunis, M. J., Mayhew, C. N., Goodson, M., Park-Sarge, O.-K., & Sarge, K. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104714200 · Cited by 266
Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition
Cunniff, C., Bassetti, J. A., & Ellis, N. A. (2017) · Molecular Syndromology · doi:10.1159/000452082 · Cited by 265
Two B or not two B? overview of the rapidly expanding B-box family of proteins
Torok, M., & Etkin, L. D. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.067003063.x · Cited by 169
Metadata
- Authors
- Duprez, E., Saurin, A. J., Desterro, J. M., Lallemand-Breitenbach, V., Howe, K., Boddy, M. N., Solomon, E., Thé, H. D., Hay, R. T., & Freemont, P. S.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 1999-02-01
- Volume
- 112
- Issue
- 3
- Pages
- 381-393
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2132147221
- Cited by
- 312
- References
- 42
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.